RESUMO
NSAIDs are promising agents for preventing cold injury (frigoprotectors). The influence of prophylactic administration of the non-selective COX inhibitor diclofenac sodium (7 mg/kg) and the highly selective COX-2 inhibitor etoricoxib (5 mg/kg) on cyclooxygenase pathway biomarkers was studied on the model of acute general cooling (air hypothermia at -18 °С for 2 hours). Diclofenac completely prevented a decrease in body temperature, surpassing etoricoxib. In the liver of the rats immediately after cold exposure, the content of COX-1 was increased moderately and the content of COX-2 highly significantly. Very significantly, the level of PGE2 decreased, and the levels of PGF2α, especially PGI2 and TXB2, were elevated. In the blood serum, the level of COX-1 was decreased, and the changes in COX-2 and prostaglandins levels were similar to those in the liver. Diclofenac exerted a moderate effect towards the normalization of both COX isoforms in the liver, moderately increased the content of PGE2, and decreased - PGF2α and TXB2 without changing the level of PGI2. In serum, diclofenac reduced COX-1 level to subnormal values, and its effect on other biomarkers was similar to that in the liver, except for a moderate decrease in PGI2. Thus, diclofenac was inferior to etoricoxib, which normalized COX-1, COX-2, PGE2, and PGI2 in the liver and reduced the content of PGF2α and TXB2 in the liver to subnormal values. At the same time, in the blood serum, it decreased COX-1, COX-2, and PGE2 to subnormal values, normalized PGF2α, and PGI2, and significantly reduced TXB2. The opposite degree of intensity of the influence of diclofenac and etoricoxib on the cyclooxygenase pathway and body temperature indicates a dissociation of anti-inflammatory and frigoprotective activity. Inhibition of oxidative stress is not determinative for the frigoprotective activity of NSAIDs since diclofenac, despite the weaker influence on the content of 8-isoprostane in the liver, still exerts the maximum frigoprotective activity.
Assuntos
Hipotermia , Ratos , Animais , Temperatura Corporal , Ácido Araquidônico , Diclofenaco/farmacologia , Etoricoxib , Ciclo-Oxigenase 2 , Dinoprosta , Dinoprostona , Anti-Inflamatórios não Esteroides/farmacologiaRESUMO
After more than 50 years of studying soldiers in the cold, we are well past the phase of defining the unique problems; the research requirements are known but the solutions have been slow in coming. This requires iterative testing of proposed lab-based solutions with soldiers in the real environment. Representing a renewed effort to produce and implement solutions to human biomedical challenges in Arctic operations, this journal supplement highlights presentations from a three-day NATO Human Factors and Medicine panel-sponsored symposium in Washington DC in October 2022. While technology can certainly aid soldiers in extreme environments, it is ultimately training that is the most important factor for ensuring optimal performance and survival. By investing in the development of specialized Arctic forces training and implementing new solutions to protect their health and performance, we can ensure success in the coldest and harshest of environments.
Assuntos
Militares , Humanos , Regiões Árticas , TecnologiaRESUMO
BACKGROUND: Myths, misconceptions and a general lack of information surround the use of gloves and mittens in extreme cold environments. OBJECTIVE: This study assessed how well an assortment of gloves and mittens performed in a very cold environment. METHODS: A convenience sample of gloves and mittens were tested in Antarctica during the winter of 2016 using a calibrated thermometer (range: -148°F to +158°F/-100°C to +70°C) three times over a 0.5-mile distance (~20 minutes). A small sensor on a 10-foot-long cable was taped to the radial surface of the distal small finger on the non-dominant hand. The tested clothing was donned over the probe, the maximum temperature inside the glove/mitten was established near a building exit (ambient temperature approximately 54°F/12°C), and the building was exited, initiating the test. The hand was kept immobile during the test. Some non-heated gloves were tested with chemical heat warmers placed over the volar or dorsal wrist. RESULTS: The highest starting (96°F/36°C) and ending (82°F/28°C) temperatures were with electrically heated gloves. The lowest starting temperature was with electrically heated gloves with the power off (63°F/17°C). Non-heated gloves with an inserted chemical hand warmer had the lowest minimum temperature (33°F/1°C). Maximum temperatures for gloves/mittens did not correlate well with their minimum temperature. CONCLUSIONS: Coverings that maintained finger temperatures within a comfortable and safe range (at or above 59°F/15°C) included the heated gloves and mittens (including some with the power off) and mittens with liners. Mittens without liners (shell) generally performed better than unheated gloves. Better results generally paralleled the item's cost. Inserting chemical heat warmers at the wrist increased heat loss, possibly through the exposed area around the warmer.